COMP <GO>
IART vs BBNX // RETURN ON INVESTED CAPITAL (ROIC)
Integra LifeSciences Holdings Corporation (NASDAQ) VS. Beta Bionics Inc. (NASDAQ) • 15-METRIC TALLY: IART 5
— BBNX 4
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: BBNX
LAST: $12.83 (+4.82%) • MKT CAP: $998.2M
roic
-35.00%
LAST: $17.58 (-1.51%) • MKT CAP: $955.8M
roic
-22.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IART VS. BBNX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IART | BBNX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 50.90% | 55.40% | -4.50 | BBNX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -22.10% | -12.90 | BBNX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.11% | -5.88% | +2.77 | IART | /fcf-yield <GO> |
| Operating Margin | -30.20% | -60.00% | +29.80 | IART | /operating-margins <GO> |
| Net Profit Margin | -31.60% | -60.00% | +28.40 | IART | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 53.90% | -52.40 | BBNX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.64 | 12.82 | -12.18 | BBNX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.8 | 41.5 | +1.31 | IART | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $998.2M | $955.8M | $42.4M | IART | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IART REV | BBNX REV | IART GROSS % | BBNX GROSS % | IART FCF | BBNX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.64B | $100.3M | 50.9% | 55.4% | -$31.1M | -$56.2M |
| FY 2024 | $1.61B | $65.1M | 54.8% | 55.1% | $25.0M | -$51.7M |
| FY 2023 | $1.54B | $12.0M | — | — | $140.0M | -$32.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IART // BETA —
BBNX // BETA —